BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8495498)

  • 1. Iron augments macrophage-mediated killing of Brucella abortus alone and in conjunction with interferon-gamma.
    Jiang X; Baldwin CL
    Cell Immunol; 1993 May; 148(2):397-407. PubMed ID: 8495498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide.
    Jiang X; Leonard B; Benson R; Baldwin CL
    Cell Immunol; 1993 Oct; 151(2):309-19. PubMed ID: 8402938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella abortus siderophore 2,3-dihydroxybenzoic acid protects brucellae from killing by macrophages.
    Leonard BA; Lopez-Goni I; Baldwin CL
    Vet Res; 1997; 28(1):87-92. PubMed ID: 9172844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria.
    Parent MA; Bellaire BH; Murphy EA; Roop RM; Elzer PH; Baldwin CL
    Microb Pathog; 2002 May; 32(5):239-48. PubMed ID: 12071680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages and Brucella.
    Baldwin CL; Winter AJ
    Immunol Ser; 1994; 60():363-80. PubMed ID: 8251581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contradictory roles for antibody and complement in the interaction of Brucella abortus with its host.
    Hoffmann EM; Houle JJ
    Crit Rev Microbiol; 1995; 21(3):153-63. PubMed ID: 8845060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC; Harms JS; Banai M; Splitter GA
    Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.
    Jones SM; Winter AJ
    Infect Immun; 1992 Jul; 60(7):3011-4. PubMed ID: 1612769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host interferon-γ inducible protein contributes to Brucella survival.
    Ritchie JA; Rupper A; Cardelli JA; Bellaire BH
    Front Cell Infect Microbiol; 2012; 2():55. PubMed ID: 22919646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid raft microdomains mediate class A scavenger receptor-dependent infection of Brucella abortus.
    Kim S; Watarai M; Suzuki H; Makino S; Kodama T; Shirahata T
    Microb Pathog; 2004 Jul; 37(1):11-9. PubMed ID: 15194155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage control of Brucella abortus: influence of cytokines and iron.
    Baldwin CL; Jiang X; Fernandes DM
    Trends Microbiol; 1993 Jun; 1(3):99-104. PubMed ID: 8143124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice.
    Kim S; Kurokawa D; Watanabe K; Makino S; Shirahata T; Watarai M
    FEMS Microbiol Lett; 2004 May; 234(2):289-95. PubMed ID: 15135535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Brucella abortus total RNA from B. abortus-infected murine RAW macrophages.
    Covert J; Eskra L; Splitter G
    J Microbiol Methods; 2005 Mar; 60(3):383-93. PubMed ID: 15649540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of Brucella abortus in macrophages from resistant and susceptible mouse strains.
    Sathiyaseelan J; Jiang X; Baldwin CL
    Clin Exp Immunol; 2000 Aug; 121(2):289-94. PubMed ID: 10931144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity.
    Sathiyaseelan J; Goenka R; Parent M; Benson RM; Murphy EA; Fernandes DM; Foulkes AS; Baldwin CL
    Cell Immunol; 2006 Sep; 243(1):1-9. PubMed ID: 17184756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.
    Cheers C; Waller R
    J Immunol; 1975 Sep; 115(3):844-7. PubMed ID: 807647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of integrase/recombinase xerD and monofunctional biosynthesis peptidoglycan transglycosylase genes in the pathogenicity of Brucella abortus infection in vitro and in vivo.
    Canavessi AM; Harms J; de Leon Gatti N; Splitter GA
    Microb Pathog; 2004 Nov; 37(5):241-51. PubMed ID: 15519045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice.
    Winter AJ; Duncan JR; Santisteban CG; Douglas JT; Adams LG
    Infect Immun; 1989 Nov; 57(11):3438-44. PubMed ID: 2509362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.